Literature DB >> 29137067

Harlequin syndrome and Horner syndrome after neck schwannoma excision in a pediatric patient: A case report.

Dong Hoon Lee1, Jong Yuap Seong, Tae Mi Yoon, Joon Kyoo Lee, Sang Chul Lim.   

Abstract

RATIONALE: Harlequin syndrome is an extremely rare benign condition characterized by unilateral facial flushing and sweating. PATIENT CONCERN: An 11-year-old boy presented with complaint of a right neck mass of 1-month duration. DIAGNOSIS: The preoperative diagnosis was neurogenic tumor of vagus nerve or sympathetic nerve.
INTERVENTIONS: We performed right neck mass removal under general anesthesia. OUTCOMES: We report a case of harlequin syndrome associated with Horner syndrome in an 11-year boy who underwent excision of right neck schwannoma. LESSONS: Clinicians should consider the point that harlequin syndrome could occur as a first sign of more serious conditions.

Entities:  

Mesh:

Year:  2017        PMID: 29137067      PMCID: PMC5690760          DOI: 10.1097/MD.0000000000008548

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Harlequin syndrome is an extremely rare neurological condition characterized by unilateral facial flushing and sweating.[ The etiology is not well defined and the pathophysiology is related to dysfunction of the upper sympathetic nerve.[ Herein, we report a case of harlequin syndrome associated with Horner syndrome in an 11-year-old boy who underwent excision of right neck schwannoma.

Case report

An 11-year-old boy presented with complaint of a right neck mass of 1-month duration. The patient's medical history was unremarkable. The patient denied fever, chills, pain, or tenderness. Upon physical examination, a firm, 3.0 cm sized mass was palpated in the right upper lateral neck. Neck computed tomography (CT) scans demonstrated a 3 × 4 cm sized oval, well-defined, heterogeneously enhancing mass with internal necrotic foci in the right carotid space (Fig. 1). Fine needle aspiration cytology of the right neck mass was performed: however, the adequate cell harvest was a failure because of the hardness of the mass.
Figure 1

Neck computed tomography (CT) scan demonstrate a 3 × 4 cm sized oval, well-defined, heterogeneously enhancing mass (arrow) with internal necrotic foci in the right carotid space.

Neck computed tomography (CT) scan demonstrate a 3 × 4 cm sized oval, well-defined, heterogeneously enhancing mass (arrow) with internal necrotic foci in the right carotid space. Based on these observations, the preoperative diagnosis was neurogenic tumor of vagus nerve or cervical sympathetic nerves. We explained the clinical course and surgical complications of neurogenic tumor to the patient's family and subsequently, patient's parents opted for surgical excision of right neck mass. We performed right neck mass removal under general anesthesia. Intraoperative exploration revealed a yellow colored tumor underneath the vagus nerve and carotid artery, the mass was completely excised without any damage to the surrounding structures. Few hours after the surgery, the patient developed well-demarcated skin flushing confined to the left side of his face and mild ptosis on right eye with equal and reactive pupils and normal ocular movement (Fig. 2). Facial flushing resolved spontaneously within an hour of appearance without any treatment. Harlequin syndrome and Horner syndrome were contemplated to have occurred by surgical injury of sympathetic nerve. The patient was discharged 3 days later without recurrence of facial flushing. Histological examination of the specimen revealed a schwannoma. Three months later, improvement in ptosis of right eye was noted, and the patient remained asymptomatic. Informed consent was given by the patient's parents.
Figure 2

Patient has well-demarcated skin flushing confined to the left side of his face and mild ptosis on right eye. (Informed consent was given by the patient's parents.)

Patient has well-demarcated skin flushing confined to the left side of his face and mild ptosis on right eye. (Informed consent was given by the patient's parents.)

Discussion

Harlequin syndrome is usually idiopathic; however, in some cases it has been reported to be associated with underlying lesions, such as brain stem infraction, tumor, surgery, or surgical procedures.[ In the case of our patient, harlequin syndrome and Horner syndrome were contemplated to have occurred by cervical sympathetic nerves injury and concomitant damage of the superior cervical ganglion during surgery.[ Harlequin syndrome can also be the first sign of more serious conditions, therefore, diagnostic examinations are required.[ Clinicians should refer to patient's medical history, such as previous tumor, surgery, or trauma.[ Clinical and neurological examinations should be performed to reveal the site of the sympathetic lesion.[ Radiologic examinations, such as CT, magnetic resonance imaging, ultrasound, and electrophysiological procedures should be performed to exclude the presence of an underlying disease.[ In the present case, we only performed clinical and neurologic examinations without imaging techniques, as the condition was a definite cause of harlequin and Horner syndrome. Harlequin syndrome is usually benign in nature, and does not need any specific treatment.[ Reassurance and avoidance of any aggravating factors should be provided to patients.[ In the case of our patient, harlequin syndrome spontaneously resolved without any treatment. In conclusion, harlequin syndrome is an extremely rare benign condition, and can occur by excision of neck tumor, even in a pediatric patient.[ Clinicians should consider the point that harlequin syndrome could be the first sign of more serious conditions.
  6 in total

1.  Botulinum toxin for treatment of Harlequin syndrome.

Authors:  Roberta K J V Manhães; Mariana Spitz; Luiz Felipe Vasconcellos
Journal:  Parkinsonism Relat Disord       Date:  2015-12-18       Impact factor: 4.891

2.  Transient postoperative harlequin syndrome combined with Horner's syndrome in a pediatric patient after neck mass excision.

Authors:  Hae K Kil; Won O Kim; Jang E Cho; Bon N Koo
Journal:  Paediatr Anaesth       Date:  2007-06       Impact factor: 2.556

3.  Harlequin syndrome post-transsphenoidal pituitary macroadenoma surgery.

Authors:  Gonzalo Díaz-Soto; Maria J Vaquerizo; Ciro Garcίa-Álvarez; Aurelia Villar-Bonet
Journal:  Hormones (Athens)       Date:  2012 Apr-Jun       Impact factor: 2.885

4.  Harlequin syndrome--one face of many etiologies.

Authors:  Gunnar Wasner; Rainer Maag; Janne Ludwig; Andreas Binder; Jörn Schattschneider; Robert Stingele; Ralf Baron
Journal:  Nat Clin Pract Neurol       Date:  2005-11

5.  Harlequin Syndrome after Stellate Ganglia Neuroblastoma Resection.

Authors:  Sabine Irtan; Anne Auvrignon
Journal:  J Pediatr       Date:  2016-06-22       Impact factor: 4.406

6.  Harlequin Syndrome Following Implantation of Intrathecal Pumps: A Case Series.

Authors:  Nantthasorn Zinboonyahgoon; Suresh Srinivasan; Sanjeet Narang
Journal:  Neuromodulation       Date:  2015-09-24
  6 in total
  4 in total

1.  Harlequin Syndrome after Thoracoscopic Repair of a Child with Tracheoesophageal Fistula (TEF).

Authors:  Richard Wagner; Martin Lacher; Andreas Merkenschlager; Moritz Markel
Journal:  European J Pediatr Surg Rep       Date:  2019-09-26

2.  Harlequin syndrome induced by intraspinal analgesia in patients with advanced cancer: a case report.

Authors:  Rong Yan; Chengxue Dang; Wei Yuan
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

Review 3.  Mini-Review on the Harlequin Syndrome-A Rare Dysautonomic Manifestation Requiring Attention.

Authors:  Ioannis Mavroudis; Ioana-Miruna Balmus; Alin Ciobica; Alina-Costina Luca; Rumana Chowdhury; Alin-Constantin Iordache; Dragos Lucian Gorgan; Iulian Radu
Journal:  Medicina (Kaunas)       Date:  2022-07-15       Impact factor: 2.948

4.  Harlequin syndrome following microwave ablation in a child with a symptomatic paraspinal mass.

Authors:  Lauren Schultz; Amelia Mackarey; Caleb Oh; Paul Kent
Journal:  BMJ Case Rep       Date:  2020-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.